Medium-term outcomes following contemporary transcatheter aortic valve implantation in England: insights from national registry linkage

31 August 2026 (14:30 - 14:45)

Organised by:

About the speaker

Professor Rajesh Kharbanda

Oxford University Hospitals NHS Trust, Oxford (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail

Primary Results of the VHD-W (Valvular Heart Disease in Women) Study

Doctor J. Grapsa (Boston, US)

Presentation thumbnail

Isolated Tricuspid Valve Replacement at 20-Year Follow-up. Insight from the largest multicenter international registry. DURABLE Tricuspid

Doctor E. Zancanaro (Mainz, DE)

Presentation thumbnail

How Much Tricuspid Regurgitation Reduction Is Enough? Residual TR and Long-Term Outcomes After T-TEER in the Randomized TRI-FR Extension

Professor E. Donal (Rennes, FR)

Access the full session

Session thumbnail

Valvular heart disease: lessons from real-world practice

The Event

Event poster

ESC Congress 2026

31 August 2026 14:30 CET

You may be interested in

Congress Session

ESC Paul Hugenholtz Lecture in Innovation

25 August 2023

Congress Presentation

Disparities in outcomes of Transcatheter Aortic Valve Replacement among patients with heart failure: a nationwide study in unites states from 2012-2018

22 May 2022

Congress Presentation

Transcatheter aortic valve implantation in young patients: a propensity score-matched analysis

27 August 2023

Congress Presentation

Predictors, feasibility and outcomes of coronary interventions up to 3 years after TAVI with a balloon-expandable valve. Results from a large European multicenter registry.

2 September 2019

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources